Humanwell Healthcare (600079.SH): Sugammadex Sodium Injection receives marketing authorization from the UK Medicines and Healthcare products Regulatory Agency

16:06 13/10/2026

Humanwell Healthcare (600079.SH) announced that recently, its controlling subsidiary Yichang Humanwell Pharmaceutical Co., Ltd. (referred to as "Yichang Humanwell", in which the company holds 80% equity) received a marketing authorization approval letter issued by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for Sugammadex Sodium Injection.

Humanwell Healthcare (600079.SH) announced that recently, its controlling subsidiary Yichang Humanwell Pharmaceutical Co., Ltd. ("Yichang Humanwell", in which the Company holds an 80% equity interest) received a marketing authorization approval letter issued by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for Sugammadex Sodium Injection. The marketing authorization from the UK MHRA for Sugammadex Sodium Injection covers the following approved indications: reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults; for pediatric patients from birth to 17 years of age, it is currently recommended only for routine reversal of rocuronium-induced blockade.

TRULY INT'L (00732) repurchased 452,000 shares on October 13 for HK$379,700.

Anhui Hwasu Co.,Ltd.(600935.SH): Wantou Industrial plans to reduce its shareholding by no more than 1%.

BeiJing StarNeto Technology (002829.SZ) has been suspended from procurement qualifications across the entire military, which will have a certain impact on the company's operations in the short term.

TRULY INT'L (00732) repurchased 452,000 shares on October 13 for HK$379,700.

Anhui Hwasu Co.,Ltd.(600935.SH): Wantou Industrial plans to reduce its shareholding by no more than 1%.

BeiJing StarNeto Technology (002829.SZ) has been suspended from procurement qualifications across the entire military, which will have a certain impact on the company's operations in the short term.